Skip to Main Content

The understanding of hematology is more than ever dependent upon an appreciation of genetic principles and the tools that can be used to study genetic variation. All of the genetic information that makes up an organism is encoded in the DNA. This information is transcribed into messenger ribonucleic acid (mRNA) and then the triplet code of those mRNAs that encode proteins is translated into protein. Changes that affect the DNA or RNA sequence or its expression, either in the germ line or acquired after birth, can cause many hematologic disorders. These may be mutations that change the DNA sequence, including single base changes, deletions, insertion, and duplications, or they may be epigenetic changes that affect gene expression without any change in the DNA sequence.

The detection of defined mutations that cause a variety of diseases is now possible and has become a routine method for the diagnosis of some disorders. The development of methods to disrupt or to prevent expression of specific genes has made it possible to produce mouse models of human hematologic diseases, and such models have the potential to serve as means to better understand pathophysiology and to study treatment strategies.

Inheritance patterns depend upon the biologic effect and chromosomal location of the mutation. Common autosomal recessive hematologic diseases include sickle cell disease, the thalassemias, and Gaucher disease. Hereditary spherocytosis, thrombophilia caused by factor V Leiden, most forms of von Willebrand disease, and acute intermittent porphyria are characterized by autosomal dominant inheritance. Mutations that cause glucose-6-phosphate dehydrogenase deficiency, hemophilia A and B, and the most common form of chronic granulomatous disease, are all carried on the X chromosome and therefore manifest X-linked inheritance, with transmission of the disease state from a heterozygous mother to her son. Understanding the genetics of a disorder is necessary for accurate genetic counseling.

Acronyms and Abbreviations

Acronyms and abbreviations that appear in this chapter include: ARMS, amplification refractory mutation system; ASOH, allele-specific oligonucleotide hybridization; BACs, bacterial artificial chromosomes; bp, base pairs; cDNA, complementary DNA; CRM, cross-reacting material; CpG, cytosine phosphate guanine; ENU, N-ethyl-N-nitrosourea; G-6-PD, glucose-6-phosphate dehydrogenase; GTP, guanosine triphosphate; IAP, intra-cisternal A particle; HUMARA, human androgen receptor X-chromosome inactivation assay; mRNA, messenger ribonucleic acid; miRNA, microribonucleic acid; mtDNA, mitochondrial DNA; NADH, nicotinamide adenine dinucleotide (reduced form); PACs, P1-derived artificial chromosomes; PCR, polymerase chain reaction; PNH, paroxysmal nocturnal hemoglobinuria; RF, release factor; RFLP, restriction fragment length polymorphism; RISC, RNA-induced silencing complex; RNAi, RNA interference; rRNA, ribosomal ribonucleic acid; RT-PCR, reverse transcriptase polymerase chain reaction; siRNA, small interfering ribonucleic acid; SNP, single nucleotide polymorphism; SSCP, single stranded conformation polymorphism; TpG, thymine phosphate guanine; tRNA, transfer ribonucleic acid; UDP, uridine diphosphate; YAC, yeast artificial chromosome.

Many of the hematologic diseases described in this text have a genetic basis. Often the disease is caused by a mutation in a single gene. Some of these disorders, such as sickle cell disease (Chap. 48...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.